Desensitization Therapy for Children with Bronchial Asthma

Authors

  • A. M. Giurnazi Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Al-Fateh University for Medical Sciences, Tripoli, Libya
  • E. T. S. Ben Ahmaida Department of Medical Microbiology and Immunology, Faculty of Medicine, Al-Fateh University for Medical Sciences, Tripoli, Libya
  • Z. R. Al-Sherif Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Al-Fateh University for Medical Sciences, Tripoli, Libya
  • A. M. Al-Sherif Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Al-Fateh University for Medical Sciences, Tripoli, Libya
  • A. A. Bouaeshi Department of Nephrology, Tripoli Children Hospital, Faculty of Medicine, Al-Fateh University for Medical Sciences, Tripoli, Libya
  • A. Dau Masaud Department of Pharmacology, Faculty of Medicine, Sebha University, Sebha, Libya

DOI:

https://doi.org/10.51984/sbep3s80

Keywords:

Bronchial asthma, Allergen immunotherapy, Desensitization, IgE, House dust mite, Children

Abstract

Bronchial asthma a disease of the airways is one of the most common chronic diseases, affecting about 200 million people of all ages worldwide.

Optimal long-term treatment and regular follow-up in specialized respiratory clinic are essential if the asthmatic children are to lead as normal a life as possible.

This project has been concentrated on study of the affect of immunotherapy as a method for treatment of bronchial asthma and allergic rhinitis, including minimization of chronic asthma symptoms, reducing number of bronchospasm attacks, maintenance of normal lung function and side effects.

The study was performed for (200) patients; periodically visiting the private respiratory clinic. All patients received desensitization therapy in conjunction with inhaled steroid therapy.

The study shows that detection of high level of IgE antibodies is of great value in support of the diagnosis of allergic disease, three hundred and thirty six patients (88%) patients involved in the study, had high levels of IgE antibodies, while 44 (12%) patients had normal levels of IgE antibodies ,For patients with high levels of IgE antibodies, skin test is indicated, there was high incidence of bronchial asthma due to sensitization for house dust mites antigen (88%), while other sensitization for other allergens with small percentages.

A remarkable improvement is recorded in desensitization therapy, normal or near normal lung function was recorded (95.5%).

Immunotherapy is promising method for treating bronchial asthma and allergic rhinitis.

Downloads

Download data is not yet available.

References

Pathophysiology and Treatment of Asthma, Pharmacy Times, by Dr. Bruyere is Professor of Pathology and Toxicology and Dr. Culver is Associate Professor of Pharmacology at The University of Wyoming School of Pharmacy, Laramie, WY. http://secure.pharmacytimes. com/ lessons/html/asthma2001. tm#Conclusion

Managing House Dust Mites 2006, by Barb Ogg , PhD, Extension Educator, University of Nebraska-Lincoln Extension in Lancaster country. http: //Lancaster .unl.edu/ pest/ resources/ DustMites311. shtml

Clinical symposia, management of asthma ,by Paul v. Williams .MD 49(3)1997(16)

Spirometry, www.drgeen.com/ 21-1358. html.

Diagnosis treatment and prevention of allergic disease; the basics, by Jo A Douglass and Robyn E O hehir- the medical Journal of Australia- MJA Practice Essentials –Allergy –MJA 2006; 185(4); 228-233- SERIES EDITORS; Andrew Kemp, Raymond Mullins, John Weiner http;//www.mja.com. au/ puplic/ issues/185-04-21`0806/dou10258-fm.html.

Downloads

Published

2009-06-01

How to Cite

1.
Giurnazi AM, Ben Ahmaida ETS, Al-Sherif ZR, Al-Sherif AM, Bouaeshi AA, Masaud AD. Desensitization Therapy for Children with Bronchial Asthma. J Med Sci (Sebha) [Internet]. 2009 Jun. 1 [cited 2026 Nov. 16];8(2):30-4. Available from: https://sebhau.edu.ly/journal/joms/article/view/5164

Similar Articles

1-10 of 33

You may also start an advanced similarity search for this article.